abc-Analyz Diagnostics A/S: Financial statements 2021
CVR: 40871691
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
abc-Analyz Diagnostics A/S (CVR 40871691) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 663,887 and a net result of DKK 2,365. The profit margin was 0.4%. Equity in the 2021 report amounted to DKK 359,054. The solvency ratio was 15.4%. The company had 1 employee in the financial year.
- Revenue
- DKK 663,887
- Gross Profit
- DKK 871,462
- Profit/Loss
- DKK 2,365
- Equity
- DKK 359,054
- Total Assets
- DKK 2,331,348
- Employees
- 1
Official annual report
Find more companies like abc-Analyz Diagnostics A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Abc-Analyz Diagnostics A/S has published its interim report for the period October 10, 2019 – December 31, 2020.
About abc-Analyz Diagnostics A/S
abc-Analyz Diagnostics A/S is a Danish company of the type Aktieselskab based in Næstved, founded in 2019. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named LumiraDx A/S. The management consists of Björn Eric Christer Gillberg. The board consists of Björn Eric Christer Gillberg, Jenny Brita Gillberg and Peter Christian van Schaik. The company is owned by Peter Christian van Schaik and RGE AB. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK 127,817 and a net result of DKK 74,424 compared with DKK -26,186 the year before. Equity in the 2025 report amounted to DKK 338,721.